Food & Drug Administration news
The coronavirus shots target an omicron variant named XBB.1.5. That specific strain is no longer dominant but it’s close enough to coronavirus strains causing most COVID-19 illnesses today that FDA determined it would offer good cross-protection.
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
Thursday, the Food and Drug Administration's scientific advisers reviewed whether the next round of shots in the U.S. should only include protection against the newest variants that are now dominant worldwide — a branch of the omicron family tree named XBB.
Federal health advisers said Wednesday that a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the first over-the-counter contraceptive medication.
The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.
A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription
Federal health officials on Thursday ordered Juul to pull its electronic cigarettes from the U.S. market, the latest blow to the embattled company widely blamed for sparking a national surge in teen vaping.
Unlike the products approved or authorized by the FDA, fraudulent products that claim to cure, treat, or prevent COVID-19 haven’t been evaluated by the agency for safety and effectiveness and might be dangerous to you and your family.